Purpose: Validating cases of acute liver injury (ALI) in health care data sources is challenging. Previous validation studies reported low positive predictive values (PPVs).
| INTRODUCTION
Acute liver injury (ALI) is defined as a sudden appearance of liver test abnormalities and includes a broad spectrum of clinical scenarios, ranging from mild abnormal biochemical liver values to acute liver failure. 1, 2 Previous validation studies have shown that identification of potential ALI events through diagnosis and procedural codes is challenging and that most validated algorithms have positive predictive values (PPVs) below 60%, [3] [4] [5] except in one study, which reported PPVs >75%. 6 All previous studies highlight the need for validation by medical record review when conducting studies of ALI based on automated health care data sources. This is especially important in drug safety studies, in which reliance on algorithms alone for automated case identification will most likely result in misclassification and overestimation of the true incidence of ALI and biased effect estimates.
As part of a recent post-authorization safety study (PASS) conducted in five European data sources investigating the potential risk of ALI associated with the use of agomelatine and nine other antidepressant drugs, 7 validation of the algorithms used to identify ALI cases was conducted. This was done via medical record review in three of those data sources: two Spanish health care databases and the Danish National Health Registers.
| METHODS
The objective of this study was to determine the ability of three ALI definitions to correctly identify ALI cases in three automated health care data sources. Specifically, we aimed to validate the following:
• An ALI definition including only main hospital discharge diagnosis specific codes
• An ALI definition including main hospital discharge diagnosis specific and nonspecific codes
• An ALI definition including main hospital discharge and also outpatient diagnosis codes (both specific and nonspecific)
| Study setting
Five automated health care databases were used in the agomelatine PASS. 7 Three of these were used to conduct a validation study: in Spain, the EpiChron Cohort Study from Aragon Health Sciences Institute (Aragón, Spain) 8 and the Information System for Research in Primary Care (SIDIAP) (Catalonia, Spain) 9 ; and in Denmark, the Danish National Health Registers (Denmark). 10, 11 The main characteristics of each database are included in Supplementary eTable S1. Of the two databases that were not used, validation by review of medical records
is not an option in the German Pharmacoepidemiological Research Database (GePaRD) (Germany) [12] [13] [14] and was not feasible within the study timeframe in the Swedish National Registers (Sweden). 15, 16 Nevertheless, an external validation study was conducted in Germany, 17 the results of which will be presented in a separate publication. were excluded from the study cohort (Supplementary eMethods).
| Identification and definition of ALI
Three algorithms corresponding to three ALI definitions were used in the agomelatine PASS to automatically identify potential ALI cases based on diagnosis codes (Table 1) . 7, 18 These definitions include combinations of codes that have shown higher (specific) or lower (nonspecific) PPVs in previous validation studies. [3] [4] [5] [6] The primary ALI definition was defined as any patient with a specific main hospital discharge Table 2 ). The primary ALI definition was
KEY POINTS
• Case validation of acute liver injury (ALI) was conducted in two Spanish databases, EpiChron and SIDIAP, and in the Danish national registers.
• Validation of potential cases included patient profiles review and adjudication based on clinical data extracted from medical records.
• The overall PPVs obtained were higher for specific than for nonspecific codes and for hospital discharge than for outpatient codes.
• The nonspecific code "unspecified jaundice" had high
PPVs for all ALI definitions in Denmark but not in the Spanish databases.
• To maximize validity, studies on ALI should prioritize hospital specific discharge codes.
not validated per se, but the specific codes identifying the primary ALI definition were included in the secondary ALI definition, which underwent validation. The algorithm used to identify potential cases of the secondary study ALI definition was defined as any patient with a main hospital specific or nonspecific discharge code (ICD-9-CM or ICD-10) for ALI. Finally, the algorithm for the tertiary ALI definition was assessed using specific and nonspecific codes from either ICD-9-CM or ICD-10 identified in both hospital and outpatient settings.
In EpiChron, International Classification of Primary Care (ICPC) codes were used to identify outpatient cases of the tertiary ALI definition and ICD-9-CM to identify hospital cases. In SIDIAP, ICD-10-CM was used to identify primary care diagnoses and ICD-9-CM to identify hospital cases. In Denmark, primary care codes were not available, and therefore only hospital ICD-10 codes were used both for case identification and to apply exclusion criteria. The interplay between the three ALI definitions is displayed in Figure 1 .
| Diagnostic criteria for ALI
Potential cases of ALI identified with the electronic algorithms and reviewed by adjudicators were considered confirmed (true positives) 19 if any of the following three qualifying criteria for increases in serum levels with <1 year of persistence were met (aspartate transaminase
[AST] levels could be used instead of ALT levels only if ALT levels were unavailable and there was no known muscle pathology driving the rise in AST):
• ≥ 5 x upper limit of normal (ULN) alanine aminotransferase (ALT)
• ≥ 2 x ULN alkaline phosphatase (ALP)
• ≥ 3 x ULN ALT and > 2 x ULN bilirubin
The requirement of less than 1 year of persistence of the liver function test abnormalities was introduced to ensure that cases had ALI and not chronic liver injury. 19 This criterion was evaluated using the most recent liver enzymes results from the period 12 to 24 months before the index date to check whether they were not elevated beyond 10% of the ULN (if no results were available, the criterion was considered as met).
A false-positive case of ALI was defined as a potential case with enough data to be evaluated but that did not meet the criteria to be classified as a confirmed case of ALI. A nonevaluable case of ALI was defined as a potential case that lacked some of the required liver enzyme results to be evaluated.
| Validation steps
The strategy for validating potential cases identified by automated algorithms across the three data sources included up to three steps: reviewed 50 potential cases, all of which were also reviewed using the automated algorithm. All potential cases were evaluated using the automated algorithm only after the kappa measuring the agreement between manual review and the algorithm reached 1.
| Statistical analyses
Validity of the electronic algorithms and individual codes used to identify potential cases of ALI for the secondary and tertiary ALI definitions were assessed by calculating the overall PPV of the algorithm, Figure 2 ).
Regarding the tertiary ALI definition, which includes the total number of cases for all ALI definitions (see Figure 1) , more than 70% of true positives in Denmark and SIDIAP and 56% of true positives in EpiChron were females. Overall, the age group with the highest number of true positives was patients 80 years and older, followed by patients aged 50 to 79 years (Supplementary eTable S4).
The overall PPVs for the algorithm used to identify potential cases of the secondary ALI definition were 65% (95% CI, 45%-81%) in EpiChron, 40% (95% CI, 19%-64%) in SIDIAP, and 70% (95% CI, 64%-77%) in Denmark ( Table 2 ). As discussed in the Methods section, the primary ALI definition was indirectly validated through the specific hospital discharge codes used in the secondary ALI definition, for which the overall PPVs were 84% (95% CI, 60%-97%) in EpiChron, 60% (95% CI, 26%-88%) in SIDIAP, and 74% (95% CI, 60%-85%) in Denmark. The overall PPVs for the specific codes were higher than those for the nonspecific codes in all data sources (Table 2 ). In EpiChron and SIDIAP, the individual specific code 570.x (acute and subacute necrosis of liver)
had the highest PPV, while the code 573.3 (hepatitis unspecified) captured the highest proportion of true positives (Table 3 ). In Denmark, the individual specific codes K71.2 (toxic liver disease with acute hepatitis) and K71.6 (toxic liver disease with hepatitis, not elsewhere specified) obtained the highest PPVs and captured the highest proportion of true positives (Table 4) . None of the nonspecific codes captured more than two true positives in EpiChron and SIDIAP (Table 3) . Conversely, in Denmark, the individual nonspecific code R17 (unspecified jaundice, excludes neonatal) contributed the largest number of true positives and had the highest PPV among all individual specific or nonspecific hospital discharge codes.
For the tertiary ALI definition, the overall PPVs were 25% (95% CI, 18%-34%) in EpiChron, 8% (95% CI, 7%-9%) in SIDIAP, and 47% (95% CI, 42%-52%) in Denmark. As observed for the secondary ALI definition, we observed higher PPVs for specific than nonspecific codes in all data sources (Table 2) . Among the individual specific codes, 570.x (acute and subacute necrosis of liver) had the highest PPV in EpiChron and SIDIAP (Table 3 and Supplementary eTable S5). In Denmark, code K71.2 (toxic liver disease with acute hepatitis) had the highest PPV among specific codes (Table 4) . Among the nonspecific codes, 782.4 
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Secondary ALI definition 0 In the sensitivity analysis including nonevaluable cases in the denominator of the PPV calculation, the overall PPVs for all study ALI definitions and for both specific and nonspecific codes were smaller than those for the main PPV analysis in all data sources (see Supplementary eTables S6 and S7).
| DISCUSSION
We observed consistently higher overall PPVs for specific ALI codes versus nonspecific codes and higher overall PPVs for hospital discharge codes versus outpatient codes. The identification of ALI cases based on hospital discharge specific codes, considered as the primary ALI definition in this study, resulted in higher PPVs when compared with most previously described algorithms. [3] [4] [5] [6] In contrast to the present study, previous studies conducted to validate ALI cases have reported PPVs below 60%, [3] [4] [5] or around 75%. 6 A recently published systematic review and meta-analysis including 29 studies validating ALI or drug-induced liver injury (DILI) (25 of them presenting PPVs) showed a pooled PPV estimate for ALI of 13.4%
(95% CI, 6.1%-22.8%) and for DILI of 15.3% (95% CI, 9.5%-22.2%). 21 The authors of that study suggested that the low PPVs observed in the studies might be explained by the low prevalence of ALI or DILI.
In addition, a different list of diagnosis codes, laboratory threshold criteria, and study drugs might be the cause of the differences between studies. When we compared our study with previous studies validating ALI definitions, we observed that our study differed from these previous studies in different ways: Bui et al 6 There are also differences in the ALI definition used in previous studies compared with the criteria used in our study, which were based on Aithal criteria. 19 Positive predictive values obtained in the present study for the ICD-9 specific codes 573.3 (hepatitis unspecified) and 570.x (acute and subacute necrosis of liver) and specific ICD-10 codes K71.2
(toxic liver disease with acute hepatitis) and K71.6 (toxic liver disease with hepatitis, not elsewhere specified) were in line with previous studies. In Udo et al, 5 the code 573.3 had a PPV of 80%. In Bui et al, 6 the PPV for individual code 570.x was 84% and for 573.3 was 76%, while the PPV for the algorithm including codes 570.x, 572.2 (hepatic coma), or 573.3 was 74%. In Lo Re et al, 3 the PPVs for individual codes ranged from 6.5% to 54.3%, the combination of codes 570.x with 572.8 (sequelae of liver disease; hepatic failure) had a PPV of 100%, and code 570.x in combination with 572.2 had a PPV of 67%. In addition, the authors calculated PPVs including patients with preexisting liver disease, and the PPVs were higher when compared with the subset of the population that excluded In SIDIAP, ICD-10 codes were used only for the outpatient codes of the study tertiary ALI definition.
b Due to data protection policies in Denmark, the exact number of cases could not be provided when the number of cases was less than five. those patients. 3 In two studies validating drug-induced ALI (DILI), 22, 23 code 573.3 (hepatitis unspecified) was the highest contributor of DILI cases.
In the present study, the nonspecific code for unspecified jaundice the tertiary ALI definition confirmed in Denmark observed in our study), but the differences when validating ALI or DILI cases must be taken into account. In addition, the study by Shin et al 23 was not restricted to hospital cases as it was in Denmark, and thus the prevalence of true ALI in populations including outpatient primary care cases should be lower, which would explain the differences observed between the two studies.
| Strengths and limitations
In terms of number of validated cases, the present validation study represents one of the largest efforts performed in Europe to validate ALI cases identified in automated health care databases, using caseidentifying algorithms, and confirmed according to consensus criteria based on the presence of elevated liver enzyme levels in blood. In addition, to the best of our knowledge, this study is the first to validate ICD-10 codes related to ALI. However, the results obtained in the present study must be evaluated in the context of its limitations.
An important limitation of this study is that, although the ALI definitions were consistent across data sources and based on blood liver enzyme levels, the approach to the evaluation of potential cases Therefore, the PPVs observed in our study might not apply directly to patient populations with characteristics different from those included in the present study or to studies using different case definitions.
| CONCLUSIONS
The PPVs obtained in this study apply to patients using antidepressants without preexisting liver disease or risk factors for ALI. Future studies evaluating ALI in these and similar data sources should prioritize use of hospital discharge and specific codes to maximize validity.
Moreover, case-identifying algorithms should include hospital ICD codes for unspecified jaundice. In studies including nonspecific codes and outpatient cases, case validation is essential. 
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